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a b s t r a c t
Ethnopharmacological relevance: Helicteres sacarolha A. St.- Hil. et al. popularly known in Brazil as ‘semente-
de-macaco’, is widely employed in the popular medicine in many of parts of Brazil in the alleviation of
symptoms of ailments such as peptic ulcer and inﬂammation. Up to the present, there is no study addressing
the gastroprotective activity of the hydroethanolic extract of H. sacarolha and its possible mechanism of
actions.
Materials and methods: The hydroethanolic (70%) extract of H. sacarolha (HEHs) was obtained by maceration.
The gastroprotective activity was assessed using gastric ulcer models induced by acidiﬁed ethanol, piroxicam,
and water restraint stress in mice and rats at doses of 20, 50 and 250 mg/kg p.o. Mechanistic studies involved
the antisecretory assay evaluated with pylorus ligation in rats and pre-treatments with appropriate
antagonists/inhibitors such as yohimbine, glibenclamide, indomethacin and L-NAME, effect on catalase and
myeloperoxidase activities and gastric mucus determination using acidiﬁed ethanol- induced ulcer in mice.
Results: HEHs at all doses tested demonstrated potent gastroprotective activities in the acute ulcer models.
The gastroprotective activity of HEHs was attenuated by pre-treatments with yohimbine, glibenclamide,
indomethacin and L-NAME. HEHs effectively reduced basal gastric juice production without any effect on the
free and total acidity. The gastroprotective action of HEHs involved increasing the antioxidant enzyme
catalase and mucus secretion and inhibition of neutrophyl inﬁltration as reﬂected by the reduction in the
myeloperoxidase activity.
Conclusion: The results of this study gave a scientiﬁc support for the popular use of the leaves of H. sacarolha
in the treatment of gastric ulcers and that it has a multi-targeted action.
& 2015 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Peptic ulcer is one of the world's major gastrointestinal disorders,
embracing both gastric and duodenal ulcers, and affecting 10% of the
world population (De Jesus et al., 2012). Gastrointestinal damage is a
common adverse effect of nonsteroidal anti-inﬂammatory drugs
(NSAIDs) use, resulting in outcomes ranging from nonspeciﬁc
abdominal pain to ulceration, haemorrhage, and death (Beck et al.,
2000). The goals of treating peptic ulcer disease are to relieve pain,
heal the ulcer and prevent ulcer recurrence (Gadekar et al., 2010). In
this aspect, medicinal plants are a good source of such therapeutic
agents for having pleiotropic effects in many cases (Gadekar et al.,
2010). In fact, herbal drugs have been proved in many cases to be
very effective in the treatment and prevention of hyperacidity, gastric
and duodenal ulcer (Leite et al., 2009).
The use of herbs as medicine is the oldest form of healthcare
known to humanity and has been used in all cultures throughout
history (Kunle et al., 2012). Moreover, the use of herbal preparations
for prevention and treatment of diseases has been on dramatic
increase in the Western nations in recent years. In fact with the
upsurge in acceptance and public interest in natural therapies in both
developing and developed countries, there is availability of these
herbal remedies not only in drug stores, but now also in food stores
and supermarkets (Ekor, 2014). Although, some of these plants have
been scientiﬁcally proved in their efﬁcacies, there are still many that
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are yet to be studied for their efﬁcacies and safety (Werner, 2014). It
is in the light of this that we accomplished this present study on a
medicinal plant from Mato Grosso State, Brazil.
The biological and pharmacological effects of some members of
the genus Helicteres employed in folk medicine have been conﬁrmed.
These include among others, anti-inﬂammatory, antioxidant, anti-
bacterial, antiviral and antihyperglycemic activities (Pohocha and
Grampurohit, 2001; Chakrabarti et al., 2002; Kumar et al., 2006,
2009; Venkatesh et al., 2007; Tambekar et al., 2008; Suthar et al.,
2009; De Melo et al., 2012; Huang et al., 2013). In addition, several
pharmacologically important secondary metabolites have also been
isolated from some of these species (Wang and Liu, 1987; Chen et al.,
1990; Venkatesh et al., 2004, 2007; Pan et al., 2008; Tambekar et al.,
2008; Bhavsar et al., 2009; Suthar et al., 2009; De Melo et al., 2012;
Huang et al., 2012, 2013; Loganayaki et al., 2013; Solanki and Shan,
2013).
Helicteres sacarolha A. St. – Hil. et al. is a native medicinal plant of
Brazil and Bolivia (Cristóbal, 2001). It is of the Malvaceae family and
belongs to the pantropical genus Helicteres that is comprised of
approximately 60 species that are native to the tropics of both
hemispheres (Goldberg, 2009). In Brazil, the plant is non endemic,
and is present in phyto-geographic areas of the Amazon, Cerrado and
Atlantic Forest, precisely, in North, Northeast, Midwest and Southeast
of Brazil. It is popularly known in Brazil as ‘semente-de-macaco’,
‘saca-rolhas’, ‘rosquinha’ or ‘rosquinha-de-gato’ (Franceschinelli and
Bawa, 2005; Balogun et al., 2014).
The medicinal use of this plant and its description were ﬁrst
documented by the naturalist Saint-Hilaire in 1824 in his book
‘Plantes usuelles des brésiliens’ (Commonly used plants of Brazil),
where he stated that the decoction of the root of the plant is used
in the treatment of venereal disorders (Brandão et al., 2012).
Preparations from its root or leaves, in the forms of decoction,
infusion or maceration are used in the Brazilian popular medicine
in the alleviation of gastric ulcer symptoms, hypertension, liver
problems, inﬂammation of the ovaries, itching and diarrhoea due
to teeth eruption in children, blood depurative and in the manage-
ment of women recuperating from child birth (Truiti et al., 2005;
Borba and Macedo, 2006; Déborah Luíza and Guarim-Neto, 2009;
Silva et al., 2010; Bieski et al., 2012).
We recently reported in our laboratory, the high safety margin
of the hydroethanolic extract of H. sacarolha in the in vivo acute
and subchronic toxicities studies in mice and rats respectively, as
well as its not being cytotoxic to Chinese Hamster Ovary (CHO-k1)
epithelial cells (Balogun et al., 2014). Phytochemical analysis of the
hydroethanolic extract of H. sacarolha revealed the presence of
ellagic acid, morin and naringin (Balogun et al., 2014).
Until now, there is no available information in the literature
addressing the gastroprotective, and possible mechanism of action of
H. sacarolha despite its widespread use in ethnomedicine. The
present study therefore aimed to provide a scientiﬁc basis for its
use in popular medicine in the treatment of gastric ulcer as well as to
elucidate its possible mechanism of action using in vivo ulcer models.
2. Materials and methods
2.1. Plant material
The leaves of H. sacarolha used in this study were harvested in the
month of March, 2013 from the Bahia de Campo Community, Poconé,
Mato Grosso, Brazil. Botanical identiﬁcation was done by Professor
Germano Guarim Neto of Herbário UFMT and a voucher specimen
(no. 40722) was deposited at the same Herbarium. The plant name
was checked with www.theplantlist.org, on the 14th of August 2014.
In order to access the traditional knowledge associated with genetic
resources for research purposes from the traditional communities, an
ethical clearance (approval no. 247) from the Brazilian Ministry of
Environment, under the auspices of the Council for Genetic Heritage
Management (CGEN/MMA), was obtained.
2.2. Extract preparation
Fresh leaves of H. sacarolha (10 kg) were cleaned and dried in an
oven (Model TE-394/4; Tecnal, Brazil) at 40 1C for 72 h, pulverised in
an electric miller (Model TE-625; Tecnal, Brazil) with sieved of mesh
size 40. The powdered plant material was extracted by maceration in
70% hydroethanolic solution (1:10 w/v) for 7 days, to obtain the
hydroethanolic extract. After extraction, the solvent was partially
evaporated under reduced pressure (600 mmHg) at 40 1C in a rotary
evaporator (Model 801; Fisatom, Brazil). Residual solvent was elimi-
nated in a hot air circulating oven (Model TE-394/4; Tecnal, Brazil) at
40 1C. The extract was then lyophilised in a freeze dryer (Model LL
1500; Heto, Italy) to obtain HEHs, which was bottled in a dark ﬂask
and stored in a fridge (Model 350 L; Brastemp, Brazil) at 4 1C. The
extract yield per gram of dried powdered leaves was 10%. HEHs
hydrosoluble (500 mg/mL) and was dissolved in distilled water at the
time of use.
2.3. Animals
Albino mice Mus musculus, Swiss-Webster strain (25–30 g) and
rats Rattus norvegicus, Wistar strain (180–200 g) were used for the
studies. Animals were maintained in propylene cages at 26 1C in a
12 h light-dark cycle, with free access to standard laboratory chow
and water. Groups of ﬁve to six animals were used for each
experiment. The experimental protocol followed the International
Principles for the Biomedical Research Involving Animal (CIOMS/
WHO, 2002) and was approved by the Committee on the Use of
Animal for experimentation (CEUA/UFMT) with protocol no.
23108.060195/13-5.
2.4. Evaluation of gastroprotective effect in acute ulcer models
2.4.1. Gastric ulcer induced by acidiﬁed ethanol (EtOH/HCl)
The gastroprotective activity of HEHs was studied in EtOH/HCl-
induced gastric ulcer. The experiment was done as previously
described (Mizui and Doteuchi, 1983). Mice were distributed into
groups with 6 animals that had fasted 18 h prior to receiving an
oral dose of the vehicle, distilled water (10 mL/kg), carbenoxolone
(100 mg/kg) or HEHs (20, 50 and 250 mg/kg body wt.). After 1 h,
all groups were treated by gavage (p.o) with 0.3 mL of 60% EtOH
and 0.3 M HCl solution for gastric-ulcer induction. Animals were
killed by cervical dislocation 1 h after the administration of EtOH/
HCl, and the stomachs excised, opened along the greater curvature
and were photographed. The lesion area in each animal was
measured in mm2 and was expressed in percentage (%) in relation
to the total area of corpus using ImageJ software (Khan, 2004).
2.4.2. Gastric ulcer induced by water immersion restraint stress
(WRS)
Rats weighing 150–180 g were used in this study. Rats were
distributed into groups of 6 animals that were fasted 20 h prior to
receiving an oral dose of the vehicle, distilled water (10 mL/kg),
ranitidine (50 mg/kg) or HEHs (20, 50 and 250 mg/kg). After 30 min
of the treatments, all animals were subjected to WRS to induce
gastric ulcerations as described by Takagi and Susumu (1968). Each
animal was immobilised in an individual compartment (restraining
tube of 5.5 cm5.5 cm25.5 cm dimensions), then immersed ver-
tically to the level of the xiphoid region in a water tank containing
tap water at temperature of 22 1C. Animals remained in this position
for 7 h. After this period, all animals were sacriﬁced by cervical
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dislocation, the stomachs were removed, opened along the greater
curvature, gastric contents discarded and the mucosa was gently
washed with cold saline. Ulceration was quantiﬁed as described in
Section 2.4.1.
2.4.2.1. Histopathological evaluation of ulcerated gastric tissues. For
histological evaluation, parts of the gastric tissues obtained from each
animal were ﬁxed in 10% formalin for 24 h, dehydrated in increasing
grades of alcohol, clariﬁed in xylene and embedded in parafﬁn.
Sections (5 mm thick) were taken in the microtome HIRAX M60 (Carl
Zeiss, Germany) and stained with haematoxylin and eosin (HE). All
tissue sections were analysed with Axioscope A1 microscope (Carl
Zeiss, Germany). The images were analysed through the Axiovision
Software (Carl Zeiss, Germany) and was used for characterisation of
histopathological changes. Samples were evaluated according to the
modiﬁed criteria and previously reported (Li et al., 2013), by an
investigator unaware of the treatments. Brieﬂy, the damage scores
were categorised as follows: a segment of 1 cm of each histological
section was assessed for loss of epithelial cells (score: 0–4), oedema
in the upper mucosa (score: 0–4), haemorrhagic injury (score: 0–4),
and the presence of inﬂammatory cells (score: 0–4).
2.4.3. Gastric ulcer induced by piroxicam
The experiment was carried out as described by Puscas et al.
(1997). Gastric ulcers were induced using piroxicam (100 mg/kg p.o.),
administered to rats after a 24 h fast. HEHs (20, 50 and 250 mg/kg),
ranitidine (50 mg/kg) or vehicle was administered orally, 1 h before
the induction of gastric ulcers. The rats were sacriﬁced by cervical
dislocation four hours after ulcer induction and their stomachs
processed as described in Section 2.4.1. The length of each lesion
was measured using ImageJ software and the lesion index was
expressed as the sum of the length of the lesions (Bozkurt et al.,
1998).
2.5. Mechanisms of gastroprotective action
2.5.1. Evaluation of anti-secretory activity in pylorus ligation model
Gastric acid secretion (pylorus-ligation ulcer, PL-ulcer) by Shay
et al. (1954) method was used for this study. In rats (180–200 g)
fasted for 24 h, the effects of HEHs (20, 50 and 250 mg/kg) or
omeprazole (20 mg/kg) were evaluated on the basal gastric acid
secretion induced by 4 h-pylorus ligation. The test drugs or vehicle
(0.5 mL/100 g) were administered intraduodenally immediately after
pylorus ligation. Four hours later, the rats were sacriﬁced by cervical
dislocation. The abdomen was opened and another ligature placed
around the oesophagus close to the diaphragm. The stomachs was
removed, washed in cold saline, the gastric juice was collected in a
graduated centrifuge tube, and the juice collected was centrifuged at
1950g for 10 min. The gastric juice volume was recorded after
centrifuging, by taking into consideration the stomach debris. The
pH of the gastric juice was measured with a digital pH meter, while
the total acidity was determined by titration with 0.01 M sodium
hydroxide and the results were expressed in mEq/L/4 h.
2.5.2. Gastric ulcer induced by acidiﬁed ethanol in animals pre-
treated with L-NAME, glibenclamide, indomethacin and yohimbine
Separate experiments were conducted in order to examine the roles
of α2-receptors, prostaglandins, nitric oxide, and activation of Kþ-ATP
channel in the gastroprotective effect of HEHs (20mg/kg). Mice were
treated with appropriate antagonists, or inhibitors (Leite et al., 2009).
Brieﬂy, mice were fasted for 18 h with water ad libitum up to 1 h
before the experiment was distributed into 11 groups of 6 animals
each. Four groups were pre-treated before ulcer induction with
L-NAME (10 mg/kg ip.), glibenclamide (5 mg/kg p.o.), yohimbine
(2 mg/kg ip.) or indomethacin (10 mg/kg p.o.). Another four groups
were pre-treated with these antagonists or inhibitor 30 min before
receiving HEHs (20 mg/kg) by gavage. A group that received only
HEHs (20 mg/kg) was also included. One hour later, all animals
received 0.3 mL of EtOH/HCl to induce ulcer. One hour after ethanol
treatment, all animals were sacriﬁced, and their stomachs were
removed, opened along the greater curvature, washed in saline, and
photos taken to quantify ulcer as described in Section 2.4.1.
2.5.3. Determination of gastric mucus in the EtOH/HCl ulcer in mice
The assay was performed in EtOH/HCl-induced ulcer animals
according to the methodology described by Hariprasath et al. (2012).
The stomachs were immersed in 10 mL 0.02% Alcian blue in 0.16 M
sucrose/0.05 M sodium acetate, pH 5.8, and incubated for 24 h at
20 1C. After incubation, the stomachs were rinsed in the same
solution and then the resulting solution (extract) was centrifuged
at 2000 g for 10 min. The absorbance of the supernatant was
measured at 615 nm using a spectrophotometer. The binding mucus
in the gastric wall was calculated from the amount of Alcian blue
binding (mg/g wet tissue) using standard curve of Alcian blue.
2.5.4. Evaluation of effect of HEHs on antioxidant enzymes in mice
with EtOH/HCl ulcer
2.5.4.1. Evaluation of myeloperoxidase (MPO) activity. The stomachs
of animals previously subjected to EtOH/HCl-induced ulcer were
used to assess the gastroprotective effect of HEHs on the mucosa,
through the involvement of MPO according to the method described
by De Young et al. (1989). MPO is an enzyme found primarily
in the azurophilic granules of the neutrophils and it is commonly
used as a marker of tissue polymorphonuclear neutrophil (PMN)
content that migrate to the site of the inﬂammatory stimulus. The
homogenate from the ulcerated stomach obtained by adding
potassium phosphate buffer (200 mM) of pH 6.5 was centrifuged at
9000 g for 20 min. The pellet obtained was resuspended with 1 mL
of 80 mM potassium phosphate buffer in the presence of 0.5%
hexadecyltrimethylammonium and then sonicated for 10 s. After
homogenisation, samples were centrifuged at 11,000g for 20 min at
4 1C. In 96-well plates 30 mL of the supernatant plus 220 mL of a mix of
solutions (containing 100 mL of 80 mM potassium phosphate buffer,
85 mL of 22 mM potassium phosphate buffer and 15 mL of 0.017%
H2O2) were added. The reaction was initiated with the addition of
20 mL of tetramethylbenzidine, and the sample was incubated for
three minutes at 37 1C. The enzyme activity was determined in a
microplate reader Multiskan® (Thermo Scientiﬁc, USA) at 450 nm.
2.5.4.2. Evaluation of catalase (CAT) activity. Effect of HEHs on CAT
activity was evaluated using EtOH/HCl-ulcer model. Animals were
distributed into the following groups: sham, vehicle (10 mL/kg, p.o.),
HEHs (20, 50 and 250 mg/kg, p.o.) and carbenoxolone (100 mg/kg,
p.o.). CAT activity was measured by the decrease of hydrogen
peroxide according to a previously described method (Aebi, 1984).
The results were expressed in μmol H2O2/min/g protein. Total
proteins were determined following the method of Lowry et al.
(1951).
2.6. Statistical analysis of data
Results of parametric tests were expressed in terms of mean7
standard error of mean (S.E.M). One-way analysis of variance
(ANOVA) was used, followed by the Student–Newman–Keuls test
when statistical difference was detected among the groups, while for
non-parametric test, Kruskal–Wallis followed by Dunn's test were
used. Values of po0.05 were considered signiﬁcant.
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3. Results
3.1. Gastric ulcer induced by EtOH/HCl
Oral administration of acidiﬁed ethanol to the vehicle group
(distilled water) caused characteristic haemorrhagic lesions in the
glandular portion of the gastric mucosa (7.01%). Treatment with
HEHs at 20, 50 and 250 mg/kg, p.o. promoted signiﬁcant reductions
in the ulcerogenic response at all doses tested by 63.3% (po0.05),
78.5% (po0.01) and 89.1% (po0.01) respectively. Carbenoxolone
(100 mg/kg), the standard drug inhibited the gastric lesions by 79.6%
(po0.01) as shown in Fig. 1.
3.2. Gastric ulcer induced by water immersion and restraint stress
(WRS)
Visual inspection showed that WRS for 7 h induced serious gastric
bleeding erosions as indicated by the mucosal haemorrhage and the
percentage ulcerated area (Fig. 2). The haemorrhage was observed
mainly in the gastric body and antrum, but not in the fundus.
Pre-treatment with HEHs (20, 50 and 250mg/kg) and ranitidine
(50 mg/kg) effectively attenuated gastric ulcerations due to WRS
signiﬁcantly (po0.001) inhibiting gastric lesions appearance by 58%,
74%, 75% and 87% respectively, when compared to the vehicle control.
3.2.1. Histopathological evaluation of gastric ulcers induced by WRS
Histopathological evaluations of the gastric tissues in WRS-
ulcerated rats revealed extensive damages to the gastric mucosa
manifested as haemorrhagic damage, submucosa oedema, loss of
epithelial cells and inﬂammatory cell inﬁltration when compared
with the normal control Fig. 3A and Table 1.
Overall pre-treatment with HEHs (Fig. 3C–E) one hour to WRS-
ulcer induction demonstrated better gastroprotection as shown by
the reduced or absence of epithelial cell loss, sub-mucosal oedema
and inﬂammatory cells inﬁltration, at the highest dose used when
compared with the vehicle control group (Fig. 3 and Table 1). The
gastroprotection was more profound at the maximal dose
(250 mg/kg) with attenuations of haemorrhagic damage, oedema,
epithelial cell loss and inﬂammatory cell inﬁltration by 90.5%,
94.3%, 100% and 94.3% (po0.01) respectively. The standard drug,
ranitidine was also equally active in protecting against WRS-
induced lesions having produced 80.8%, 83.3%, 90.5% and 89%
inhibitions in the respective histopathological parameters
evaluated.
3.3. Gastric ulcer induced by piroxicam
Intragastric administration of piroxicam to rats caused various
degrees of macroscopically evident mucosal damage (Fig. 4), with the
gastric ulcer index of the vehicle treated being 13.9672.87. Pre-
treatment with HEHs at doses of only 50 and 250 mg/kg signiﬁcantly
inhibited gastric mucosal damage index by 47.5% (po0.05) and
88.2% (po0.001) respectively. Ranitidine, the standard drug attenu-
ated, in a more intense fashion, the gastric ulcerations producing
99.6% (po0.001) inhibition.
3.4. Anti-ulcerogenic mechanisms
3.4.1. Evaluation of antisecretory activity
As seen in Table 2, treatment with HEHs (20, 50 and 250 mg/kg)
had no effect on the free and total acidity, but reduces signiﬁcantly
the juice volume by 45.6%, 50.7%, and 55.8% respectively. Omeprazole
(20 mg/kg), the standard drug, reduced intensely total acidity, and
the gastric juice volume by 43.7% (po0.05) and 87.5% (po0.01),
respectively. Likewise, omeprazole caused a 2-fold increase
(po0.001) in the pH of the gastric juice when compared with the
control (Table 2).
3.4.2. Determination of gastric mucus in the EtOH/HCl ulcer in mice
Oral administration of EtOH/HCl resulted in signiﬁcant deple-
tion of mice gastric mucus. Pre-treatment with HEHs (20 and
50 mg/kg) and carbenoxolone signiﬁcantly (po0.01) prevented
mucus depletion, increasing it by 153%, 126% and 240%, respec-
tively. The mucogenic effect of HEHs decreases with the increase in
the dose in such a way that the highest dose (250 mg/kg) tested in
this study had no signiﬁcant effect on mucus production (Fig. 5).
3.4.3. Gastric ulcer induced by acidiﬁed ethanol in animals pre-
treated with L-NAME, glibenclamide, indomethacin and yohimbine
Administration of EtOH/HCl to the vehicle group produced chara-
cteristic lesions in the form of straight haemorrhages in the glandular
portion of the gastric mucosa. Treatment with HEHs (20 mg/kg)
signiﬁcantly (po0.001) attenuated gastric lesions induced by EtOH/
HCl with 62.7% inhibition in comparison with the vehicle (Fig. 6B).
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Fig. 1. Effect of orogastric administration of the hydroethanolic extract of Helicteres
sacarolha leaves (HEHs, 20, 50 and 250mg/kg, p.o.), carbenoxolone (Cbx, 100 mg/kg)
and vehicle (distilled water) on gastric ulcer induced by 60% ethanol/HCl 0.3 M in mice.
Each column represents Mean7S.E.M of 5–6 animals. One-way ANOVA followed by
Student–Newman–Keuls. *po0.05 and **po0.01 vs. vehicle.
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Fig. 2. Effect of orogastric administration of the hydroethanolic extract of Helicteres
sacarolha leaves (HEHs, 20, 50 and 250 mg/kg, p.o.), ranitidine (Ran, 50 mg/kg p.o.)
and vehicle (Veh, distilled water) on gastric ulcer lesions induced by water restrain
stress in rats. Each column represents Mean7S.E.M. of 5–6 animals. One way-
ANOVA followed by Student–Newman–Keuls. ***po0.001 vs. vehicle.
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Signiﬁcant but partial reversal of the gastroprotective effect of HEHs
was observed with yohimbine, glibenclamide, indomethacin and L-
NAME pre-treatments with 22.9%, 10.4%, 31.4% and 11.1% inhibitions,
respectively, in comparison to the vehicle group (Fig. 6A and B).
3.4.4. Evaluation of effect of HEHs on antioxidant enzymes in mice
with EtOH/HCl ulcer
3.4.4.1. Evaluation of myeloperoxidase activity. As shown in Fig. 7, in
mice with EtOH/HCl-ulcer, gastric mucosal MPO activity in the vehicle
treated group increased signiﬁcantly (po0.05) with 1.8-fold higher
mucosal MPO than the sham control. Pre-administration of HEHs (50
and 250mg/kg) and carbenoxolone (Cbx, 100 mg/kg) signiﬁcantly
(po0.05) attenuated increase in the gastric mucosal MPO activity
when compared to the vehicle control group.
3.4.4.2. Evaluation of catalase activity. Catalase activity in the
normal mice stomach was 9.22 mmol H2O2 utilised per min per g
of protein. EtOH/HCl treatment caused a 74% reduction in the
catalase activity. Compared to the ethanol group, pre-treatment
with HEHs (20, 50 and 250 mg/kg) and carbenoxolone (100 mg/kg)
signiﬁcantly augmented the activity of catalase (Fig. 8).
4. Discussion
Although the practice of herbal medicine is an old tested
system of primary health care, there is a growing need to explore
the vast potential of the medicinal plants through pharmacological
evaluations. As part of our drive towards this end, we investigated
the gastroprotective effects of HEHs in experimental rodents.
Fig. 3. Histopathological analysis indicating the effect of the hydroethanolic extract of Helicteres sacarolha leaves (HEHs) on gastric mucosa lesions induced by water restrain stress. A)
Sham, B) animals treated with the vehicleþWRS, C–E) animals treated with HEHs at 20, 50 and 250mg/kg respectively F) Animals treated with ranitidine 50mg/kg. Curved arrow
indicates epithelial damage, arrow indicates oedema and arrowhead indicates inﬂammatory cells. The quantitative results are presented in Table 2. Stain: HE. Barr: 50 mm.
Table 1
Protective effect of the hydroethanolic extract of Helicteres sacarolha leaves (HEHs, 20, 50 and 250 mg/kg) and ranitidine (50 mg/kg) on water immersion restraint stress-
induced histological lesions.
Experimental group (n¼6) Haemorrhagic damage (score 0–4) Oedema (score 0–4) Epithelial loss (score 0–4) Inﬂammatory cells (score 0–4) Total (scores 16)
Normal group 0 0 0 0 0
Vehicle 3.50 (2–4) 3.00 (2–4) 1.80 (1–3) 3.00 (2–4) 11.30 (8–14)
HEHs (20 mg/kg) 2.80 (2–3) 2.80 (2–3) 1.70 (1–3) 1.70 (1–3) 9.00 (7–11)
HEHs (50 mg/kg) 0.83 (0–2)n 0.83 (0–2) 0.33 (0–1) 0.17 (0–1)nn 2.16 (0–4)n
HEHs (250 mg/kg) 0.33 (0–1)nn 0.17 (0–1)nn 0 (0)nn 0.17 (0–1)nn 0.67 (0–2)nn
Ranitidine (50 mg/kg) 0.67 (0–2)n 0.50 (0–2)n 0.17 (0–1)n 0.33 (0–1)n 1.67 (0–5)n
Data shown are medians with minimum and maximum scores shown in brackets. Kruskal–Wallis nonparametric test followed by Dunn's test.
n po0.05 and nnpo0.01 vs. vehicle.
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The aetiology of peptic ulcer is multifactorial and therefore res-
earch into new anti-ulcer agents requires the use of models that
takes into consideration of these different aetiological factors. Animal
models of any human disease should aim to mimic the human
condition as much as possible (Lee, 2000; Jaggi et al., 2011). In this
sense we employed 3 acute gastric ulcer models. Among the principal
aetiological factors associated with peptic ulcer are the alcohol
consumption, the use of NSAIDs drugs and emotional stress (Vimala
and Gricilda Shoba, 2014).
We commenced the present investigation into the folkloric claim
of H. sacarolha use in the treatment of gastric ulcer with EtOH/HCl
ulcer, since ethanol induces ulcer by diverse mechanisms (Adinortey
et al., 2013). Besides, alcohol can produce acute inﬂammatory reac-
tions which is central to most ulcer diseases (Dixon, 2000; Andersen
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Fig. 4. Effect of orogastric administration of the hydroethanolic extract of Helicteres
sacarolha leaves (HEHs, 20, 50 and 250 mg/kg, p.o.), ranitidine (Ran, 50 mg/kg p.o.)
and vehicle (Veh, destilled water) on gastric ulcer lesions induced by piroxicam
100 mg/kg in rats. Each column represents Mean7S.E.M. of 6 animals. One-way
ANOVA followed by Student–Newman–Keuls. *po0.05 and ***po0.001 vs. vehicle.
Table 2
Effect of intraduodenal administration of the hydroethanolic extract of Helicteres
sacarolha leaves (HEHs, 20, 50 and 250 mg/kg, id.), omeprazole (20 mg/kg id.) and
vehicle (distilled water) on gastric juice parameters in rats.
Treatment pH (units) [Hþ] (mEq/mL/
4 h)
Gastric juice volume
(mL)
Vehicle 2.0570.25 4.2171.56 1.3870.29
HEHs 20 mg/kg 2.5670.12 2.0270.52 0.7570.15n
HEHs 50 mg/kg 2.0370.28 2.6470.62 0.6870.06n
HEHs 250 mg/kg 2.8970.39 2.5170.61 0.6170.10n
Omeprazole 20 mg/kg 4.6170.92nnn 0.8470.46n 0.4870.11nn
Results are in Mean7S.E.M. of 6 animals. One-way ANOVA followed by Student–
Newman–Keuls.
n po0.05, nnpo0.01 and nnnpo0.001 vs. vehicle.
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Fig. 5. Effect of orogastric administration of the hydroethanolic extract of Helicteres
sacarolha leaves (HEHs, 20, 50 and 250 mg/kg, p.o.), carbenoxolone (Cbx,100 mg/kg
p.o.) and vehicle (Veh, distilled water) on Alcian blue binding to free gastric mucus
from acidiﬁed ethanol-ulcerated mice. Sham group was subjected only to fasting.
Results are in Mean7S.E.M. of 6 animals. One-way ANOVA followed by Student–
Newman–Keuls. ##po0.01 vs. sham and nnpo0.01 vs. vehicle.
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Fig. 6. Effect of orogastric administration of the hydroethanolic extract of Helicteres
sacarolha leaves (HEHs, 20 mg/kg) in animals pre-treated with yohimbine (Yoh,
2 mg/kg ip. ), glibenclamide (Glib, 5 mg/kg po.), indomethacin (Ind, 10 mg/kg p.o.)
and Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME, 10 mg/kg ip.) on
(Fig. 7A). Results are in Mean7S.E.M. of 5–6 animals. One-way ANOVA followed by
Student–Newman–Keuls. *po0.05 vs. vehicle, #po0.05, ##po0.01 vs. HEHs.
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Fig. 7. Effect of orogastric administration of the hydroethanolic extract of Helicteres
sacarolha leaves (HEHs, 20, 50 and 250 mg/kg, p.o.), carbenoxolone (Cbx, 100 mg/kg
p.o.) and vehicle (Veh, distilled water) on myeloperoxidase activity in acidiﬁed
ethanol-ulcerated mice. Sham group was subjected only to fasting. Results are in
Mean7S.E.M. of 5–6 animals. One-way ANOVA followed by Student–Newman–
Keuls. #po0.05 vs. sham and npo0.05 vs. vehicle.
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et al., 2005; Jia et al., 2007; Beserra et al., 2011) and therefore basic
information can be gathered from this model.
The choice of the doses used in this experiment was based on a
pilot study as well as the results of toxicity studies that showed
that repeated treatment with dose with 250 mg/kg for 30 days had
no toxic effects on the treated animals (Balogun et al., 2014).
HEHs, at all doses tested, effectively protects the gastric mucosa of
the mice in dose dependent manner. Ethanol is also known to sti-
mulate inﬂammation through imbalance between pro-inﬂammatory
cytokines and anti-inﬂammatory cytokines, in addition to production
of free radicals that may help propagate inﬂammatory conditions
(Beserra et al., 2011). We therefore hypothesised that HEHs may be
acting through inhibition of inﬂammatory processes that lead to the
gastric ulcerations by possibly enhancing the mucosal defence like
mucus production and protective antioxidant enzymes and attenua-
tion of inﬂammatory inﬁltration of the neutrophils. We investigated
the veracity of this hypothesis by assessing its mucogenic and
modulation of antioxidant enzymes.
Mucus barrier may be the ﬁrst line of defence of the gastric
mucosa against ulcerogenic insults (Jain et al., 2007; Wallace,
2008). Our result demonstrates that mucus production accounts in
part for the protective effect of HEHs. However, this mechanism
alone could not account for it protective effect as the highest dose
tested demonstrated no effect on the mucus production (Fig. 5).
Furthermore, signiﬁcant reduction in inﬁltration of neutrophils
by HEHs was conﬁrmed with inhibition in the MPO activity in the
EtOH/HCl-ulcer, while it replenished the depleted catalase activity,
one of the enzymes involved in the scavenging of free radicals
(Ohta and Nishida, 2003; Li et al., 2012). Inhibition of the MPO
activity correlated well with the histopathological ﬁndings that
revealed signiﬁcant reductions in the inﬁltrations of inﬂammatory
cells into the gastric mucosa. These results further conﬁrm the
anti-inﬂammatory nature of HEHs in these ulcer models.
Serious stress can induce organ injuries or contribute to diseases,
such as gastric ulcers, hypertension and diabetes among others. WRS-
ulcer model mimics the clinical acute gastric ulcerations caused by
trauma, surgery or sepsis (Xie et al., 2005) and have been exploited to
study pathogenic mechanisms of stress related diseases as well as
useful therapeutic interventions (Ueyama et al., 1998; Bagchi et al.,
1999; Lee, 2000; Guo et al., 2012). We therefore further explored the
gastroprotective effect of HEHs using WRS-ulcer model in rats.
Our data shows that HEHs effectively suppresses WRS-induced
ulcer by inhibiting gastric ulcerations, inﬁltration of inﬂammatory
cells into the gastric mucosa, reduction or prevention of epithelial
cell loss as conﬁrmed by histological analysis. The aetiology of
stress-induced ulcer may involves the effects of hypothalamic–
pituitary–adrenal axis activation on healing, altered blood ﬂow, or
cytokine mediated impairment of mucosal defences (Alhazzani
et al., 2012; Levenstein et al., 2014).
The major limitation of clinical application of NSAIDs are serious
side-effects such as induction of acute haemorrhagic erosions, poten-
tiation of gastric ulcerogenic response to various stimuli, exaggera-
tion of colitis and impairment of healing of pre-existing ulcers
(Brzozowski and Konturek, 2008). Gastrointestinal injury caused by
NSAIDs occurs both by topical and systemic effects. The systemic
effect is mediated principally by blocking prostaglandin synthesis
through inhibition of the cyclooxygenase (COX) enzymes, COX-1 and
COX-2. We therefore evaluated the gastroprotective action of HEHs in
this ulcer model. HEHs effectively attenuated ulcerations due to
NSAID piroxicam. Thus, HEHs may be acting by increasing the
production of mucosal prostanglandins (Musumba et al., 2009).
In an attempt to evaluate the possible role of gastric secretion in
HEHs protective action we utilised pylorus ligation model in rats.
HEHs caused reduction in the volume of gastric acid secretion.
Besides reduction in the volume of the gastric secretion, no
signiﬁcant effect was observed on the pH and concentration of HCl
indicating that gastric acid secretion modulation does not have
relevant role in the gastroprotective mechanism of action of HEHs.
The incapacity of HEHs in interfering in hydrochloric acid secretion in
the gastric juice may be desirable in some situations, since gastric
acid secretion prevents microbial growth and hypergastrinaemia.
Moreover, gastric ulcer patients as a group, sometimes exhibit
normal, decreased basal or stimulated acid production, and therefore,
gastric mucosal defence is the most important in this case (Schubert
and Peura, 2008).
α2-Adrenoreceptors that are widely distributed in the gastroin-
testinal tract, play crucial role in presynaptic modulation of trans-
mitter release, and therefore in the regulation of gastrointestinal
functions (Zádori et al., 2011). Pre-treatment with yohimbine, a non-
selective α2-adrenoreceptor antagonist partially reversed the protec-
tive effect of HEHs which indicates the involvement of α2-adrenor-
eceptors. The study of Zádori et al. (2011) conﬁrmed the participation
of both α2B- and α2C -adrenoreceptor subtypes in the mediation of
centrally induced gastroprotection in mice. It is therefore plausible
that HEHs may be acting on these receptors in conferring its
gastroprotective effect in this model.
PGs are known to inhibit mast cell activation and leucocyte
adherence to the vascular endothelium, stimulate mucus and bicar-
bonate secretion, increase mucosal blood ﬂow and accelerate ulcer
healing (Tarnawski et al., 2013). It is possible that the gastroprotective
effect of HEHs is therefore partly modulated by its modulation of PGs
production.
The participation of KþATP-channel in HEHs protective effect was
evaluated with glibenclamide pre-treatment. Glibenclamide sig-
niﬁcantly, although partially, reversed the gastroprotective effect
of HEHs and suggests that, at least in part, KþATP-channel activation
is involved in HEHs gastroprotective effect. Peskar et al. (2002)
suggested that the endogenous PGs act as activators of KþATP-
channels, and that this mechanism mediates, at least in part in
the gastroprotection. It is therefore understandable that pre-
treatment with indomethacin attenuates HEHs protective action,
as shown in Fig. 6. However, further studies are necessary to prove
this hypothesis, which is beyond the scope of the present study.
To investigate the inﬂuence of endogenous NO on the gastro-
protective effects of HEHs, mice were pre-treated with inhibitor of
nitric oxide synthase (NOS), L-NAME, an analogue of L-arginine,
which is hydrolysed to produce L-nitro arginine and thereby inhibits
NOS activity. Nitric oxide (NO) is known to have a protective effect on
the gastrointestinal tract. Preclinical studies have demonstrated that
NO participates in maintaining gastric mucosal integrity, inhibiting
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Fig. 8. Effect of orogastric administration of the hydroethanolic extract of Helicteres
sacarolha leaves (HEHs, 20, 50 and 250 mg/kg, p.o.), carbenoxolone (Cbx, 100 mg/kg
p.o.) and vehicle (Veh, distilled water) on catalase activity in acidiﬁed ethanol-
ulcerated mice. Sham group was subjected only to fasting. Results are in Mean7S.
E.M. of 5–6 animals. One-way ANOVA followed by Student–Newman–Keuls.
#po0.05 vs. sham, npo0.05 and nnpo0.01 vs. vehicle.
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leucocyte adherence to the endothelium and neutrophil aggregation,
and repair of NSAID-induced damage. In addition, NO is a vasodilator
and mediates gastric blood ﬂow (Lanas, 2008; Rozza et al., 2013). Our
data demonstrates that endogenous NO production modulates the
gastroprotective effect of HEHs.
Recent report by our research group demonstrates the presence
of relatively high content of phenolics and ﬂavonoids with HPLC
analysis conﬁrming ellagic acid, morin and naringin as part of
constituents identiﬁed in HEHs (Balogun et al., 2014). In the referred
study, ellagic acid (EA) accounts for 6% of HEHs. EA is a known
phenolic compound with wide array of pharmacological activities
such as anti-inﬂammatory and gastroprotective effects including
in vivo antioxidant properties, and it has been found in many plant
extracts as part of their active principles (Solon et al., 2000;Vattem
and Shetty, 2005; Rogerio et al., 2008; Beserra et al., 2011; Huang
et al., 2011). Morin is a ﬂavonoid that is found in many fruits and
herbs and it is used as a food additive because of its antioxidant
activity (Cho et al., 2006). It also possesses anti-inﬂammatory
property (Bellik et al., 2012). Naringin, also a ﬂavonoid, is known
to possesses gastroprotective properties among others (Schmeda-
Hirschmann and Yesilada, 2005). The gastroprotective and antiox-
idant actions of HEHs may therefore be modulated, at least in part, by
the combined action of these and other yet unidentiﬁed constituents.
5. Conclusion
The gastroprotective effect of HEHs seems to have multiple
components in its action. HEHs may be protective against ulcers by
increasing the endogenous defensive factors such as PGs, NO and
mucus, stimulation of the central and or peripheral α-2 receptors of
as well as activation KþATP-channels. It inhibited gastric secretion
volume without affecting secretion of HCl. Additionally, it increases
CAT activity and inhibited inﬁltration of neutrophils into the gastric
mucosa. The gastroprotective effect of HEHs on the acute gastric
ulceration models observed in this study support the use in popular
medicine of HEHs and suggests a potential clinical application in
treating gastrointestinal injury due to ethanol, NSAIDs and stress.
Acknowledgements
We wish to express our gratitude to Conselho Nacional de
Desenvolvimento Cientíﬁco e Tecnológico (CNPq) and Instituto
Nacional de Ciência e Tecnologia em Áreas Úmidas (INAU) (No.
704792/2009) for partially funding the work, CAPES for providing
scholarship for the ﬁrst author. We are also grateful to Dr.
Germano Guarin Neto of Herbário UFMT for technical assistance
with the plant identiﬁcation. We are also full of thanks to Eduarda
Pavan and Larissa Irene da Silva for technical assistance in the
conduct of gastroprotective studies.
References
Adinortey, M.B., Ansah, C., Galyuon, I., Nyarko, A., 2013. In vivo models used for
evaluation of potential antigastroduodenal ulcer agents. Ulcers 2013, 1–12.
Aebi, H., 1984. Catalase in vitro. Methods Enzymol. 105, 121–126.
Alhazzani, W., Alshahrani, M., Moayyedi, P., Jaeschke, R., 2012. Stress ulcer
prophylaxis in critically ill patients: review of the evidence. Polskie Archiwum
Medycyny Wewnętrznej 122, 107–114.
Andersen, L.P., Holck, S., Janulaityte-Günther, D., Kupcinskas, L., Kiudelis, G.,
Jonaitis, L., Janciauskas, D., Holck, P., Bennedsen, M., Permin, H., Norn, S.,
Wadström, T., 2005. Gastric inﬂammatory markers and interleukins in patients
with functional dyspepsia, with and without Helicobacter pylori infection.
FEMS Immunol. Med. Microbiol. 44, 233–238.
Bagchi, D., Carryl, O.R., Tran, M.X., Bagchi, M., Garg, A., Milnes, M.M., Williams, C.B.,
Balmoori, J., Bagchi, D.J., Mitra, S., Stohs, S.J., 1999. Acute and chronic stress-
induced oxidative gastrointestinal mucosal injury in rats and protection by
bismuth subsalicylate. Mol. Cell. Biochem. 196, 109–116.
Balogun, S.O., da Silva, I.F., Colodel, E.M., de Oliveira, R.G., Ascêncio, S.D., Martins,
D.T. de O., 2014. Toxicological evaluation of hydroethanolic extract of Helicteres
sacarolha A. St.- Hil. et al. J. Ethnopharmacol. 157, 285–291.
Beck, P.L., Xavier, R., Lu, N., Nanda, N.N., Dinauer, M., Podolsky, D.K., Seed, B., 2000.
Mechanisms of NSAID-induced gastrointestinal injury deﬁned using mutant
mice. Gastroenterology 119, 699–705.
Bellik, Y., Boukraâ, L., Alzahrani, H.A., Bakhotmah, B.A., Abdellah, F., Hammoudi,
S.M., Iguer-Ouada, M., 2012. Molecular mechanism underlying anti-
inﬂammatory and anti-allergic activities of phytochemicals: an update. Mole-
cules 18, 322–353.
Beserra, A.M.S.E.S., Calegari, P.I., Souza, M., do, C., Dos Santos, R.A.N., Lima, J.C., da,
S., Silva, R.M., Balogun, S.O., Martins, D.T.D.O., 2011. Gastroprotective and ulcer-
healing mechanisms of ellagic acid in experimental rats. J. Agric. Food Chem.
59, 6957–6965.
Bhavsar, S.K., Singh, S., Giri, S., Jain, M.R., Santani, D.D., 2009. Effect of saponins from
Helicteres isora on lipid and glucose metabolism regulating genes expression.
J. Ethnopharmacol. 124, 426–433.
Bieski, I.G.C., Rios Santos, F., de Oliveira, R.M., Espinosa, M.M., Macedo, M., Albuquerque, U.
P., de Oliveira Martins, D.T., 2012. Ethnopharmacology of medicinal plants of the
Pantanal Region (Mato Grosso, Brazil). Evid.-Based Complement. Altern. Med. 2012, 36.
Borba, A., Macedo, M., 2006. Plantas medicinais usadas para a saúde bucal pela
comunidade do bairro Santa Cruz, Chapada dos Guimarães, MT, Brasil. Acta
Botanica Brasilica 20, 771–782.
Bozkurt, A., Yuksel, M., Haklar, G., Kurtel, H., Yegen, B.C., Alican, I., Yüksel, M., Yeğen,
B.C., 1998. Adenosine protects against indomethacin-induced gastric damage in
rats. Dig. Dis. Sci. 43, 1258–1263.
Brandão, M.G.L., Pignal, M., Romaniuc, S., Grael, C.F.F., Fagg, C.W., 2012. Useful
Brazilian plants listed in the ﬁeld books of the French naturalist Auguste de
Saint-Hilaire (1779–1853). J. Ethnopharmacol. 143, 488–500.
Brzozowski, T., Konturek, P., 2008. Physiological mediators in nonsteroidal anti-
inﬂammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense
and adaptation. Focus on nitric oxide. J.Physiol. Pharmacol. 59, 89–102.
Chakrabarti, R., Vikramadithyan, R.K., Mullangi, R., Sharma, V.M., Jagadheshan,
H., Rao, Y.N., Sairam, P., Rajagopalan, R., 2002. Antidiabetic and hypolipidemic
activity of Helicteres isora in animal models. J. Ethnopharmacol. 81, 343–349.
Chen, C.-M., Chen, Z.-T., Hong, Y.-L., 1990. A mansonone from Helicteres angustifolia.
Phytochemistry 29, 980–982.
Cho, Y., Onodera, H., Ueda, M., 2006. A 13-week subchronic toxicity study of dietary
administered morin in F344 rats. Food Chem. Toxicol. 44, 891–897.
CIOMS/WHO, 2002. International ethical guidelines for biomedical research invol-
ving human subjects. Bull. Med. Ethics, 17–23.
Cristóbal, C.L., 2001. Taxonomía del género Helicteres (Sterculiaceae). Revisión de
las especies americanas. Bonplandia 11, 1–206.
De Jesus, N.Z.T., de Souza Falcão, H., Gomes, I.F., de Almeida Leite, T.J., de Morais
Lima, G.R., Barbosa-Filho, J.M., Tavares, J.F., da Silva, M.S., de Athayde-Filho, P.F.,
Batista, L.M., 2012. Tannins, peptic ulcers and related mechanisms. Int. J. Mol.
Sci. 13, 3203–3228.
De Melo, J.O., de Arruda, L.L.M., Baroni, S., Truiti, C.T.M., Caparroz-Assef, S.M.,
Cuman, R.K.N., Bersani-Amado, C.A., 2012. Inhibitory effect of Helicteres
gardneriana ethanol extract on acute inﬂammation. Evid.-Based Complement.
Altern. Med. 2012.
Leite, De O, da Penha, G., Fernandes, A.R., Souza, C.N., da Costa, H.H.F., Campos, A.R.,
J.G.M., 2009. Gastroprotective mechanism of Vanillosmopsis arborea bark
essential oil. Fitoterapia 80, 77–80.
De Young, L.M., Kheifets, J.B., Ballaron, S.J., Young, J.M., 1989. Edema and cell inﬁltration
in the phorbol ester-treated mouse ear are temporally separate and can be
differentially modulated by pharmacologic agents. Agents Actions 26, 335–341.
Déborah Luíza, M., Guarim-Neto, G., 2009. Multiple Uses of Plants of Brazilian
Cerrado: an ethnobotanical study of the Sítio Pindura Community, Rosary
Oeste, Mato Grosso, Brazil (Usos Múltiplos De Plantas Do Cerrado: um Estudo
Etnobotânico Na Comunidade Sítio Pindura, Rosário Oeste, Mato Grosso).
Polibotánica 159–190.
Dixon, M.F., 2000. Patterns of inﬂammation linked to ulcer disease. Best Pract. Res.
Clin. Gastroenterol. 14, 27–40.
Ekor, M., 2014. The growing use of herbal medicines: issues relating to adverse
reactions and challenges in monitoring safety. Front. Pharmacol. 4, 177. http:
//dx.doi.org/10.3389/fphar.2013.00177.
Franceschinelli, E., Bawa, K., 2005. The post-ﬁre effects on the outcrossing rate of a
Brazilian savannah shrub, Helicteres sacarolha A. St.-Hil. Braz. J. Bot. 28, 163–170.
Gadekar, R., Singour, P.K., Chaurasiya, P.K., Pawar, R.S., Patil, U.K., 2010. A potential
of some medicinal plants as an antiulcer agents. Pharmacogn. Rev. 4, 136–146.
Goldberg, L., 2009. production and composition, and morphology of ﬂoral nectaries
in Helicteres guazumifolia and Helicteres baruensis (Sterculiaceae): two sympa-
tric species. Revista de Biología Tropica 57, 161–177.
Guo, S., Gao, Q., Jiao, Q., Hao, W., Gao, X., Cao, J.-M., 2012. Gastric mucosal damage in
water immersion stress: mechanism and prevention with GHRP-6. World
J. Gastroenterol. 18, 3145–3155.
Hariprasath, L., Raman, J., Nanjian, R., 2012. Gastroprotective effect of Senecio
candicans DC on experimental ulcer models. J. Ethnopharmacol. 140, 145–150.
Huang, Q., Huang, R., Wei, L., Chen, Y., Lv, S., Liang, C., Zhang, X., Yin, F., Li, H., Zhuo,
L., Lin, X., 2013. Antiviral activity of methyl helicterate isolated from Helicteres
angustifolia (Sterculiaceae) against hepatitis B virus. Antivir. Res. 100, 373–381.
Huang, Q., Li, Y., Zhang, S., Huang, R., Zheng, L., Wei, L., He, M., Liao, M., Li, L., Zhuo,
L., Lin, X., 2012. Effect and mechanism of methyl helicterate isolated from
Helicteres angustifolia (Sterculiaceae) on hepatic ﬁbrosis induced by carbon
tetrachloride in rats. J. Ethnopharmacol. 143, 889–895.
S.O. Balogun et al. / Journal of Ethnopharmacology 166 (2015) 176–184 183
Huang, S.-T., Wang, C.-Y., Yang, R.-C., Wu, H.-T., Yang, S.-H., Cheng, Y.-C., Pang, J.-H.S.,
2011. Ellagic Acid, the active compound of Phyllanthus urinaria, exerts in vivo
anti-angiogenic effect and inhibits MMP-2 activity. Evid.-Based Complement.
Altern. Med. : eCAM 2011, 215035.
Jaggi, A.S., Bhatia, N., Kumar, N., Singh, N., Anand, P., Dhawan, R., 2011. A review on
animal models for screening potential anti-stress agents. Neurological Sci. 32,
993–1005.
Jain, K.S., Shah, A.K., Bariwal, J., Shelke, S.M., Kale, A.P., Jagtap, J.R., Bhosale, A.V.,
2007. Recent advances in proton pump inhibitors and management of acid-
peptic disorders. Bioorgan. Med. Chem. 15, 1181–1205.
Jia, Y.-T., Ma, B., Wei, W., Xu, Y., Wang, Y., Tang, H.-T., Xia, Z.-F., 2007. Sustained
activation of nuclear factor-kappaB by reactive oxygen species is involved in the
pathogenesis of stress-induced gastric damage in rats. Crit. Care Med. 35,
1582–1591.
Khan, H.A., 2004. Computer-assisted visualization and quantitation of experimental
gastric lesions in rats. J. Pharmacol. Toxicol. Methods 49, 89–95.
Kumar, G., Banu, G.S., Murugesan, A.G., Pandian, M.R., 2006. Hypoglycaemic effect
of Helicteres isora barks extract in rats. J. Ethnopharmacol. 107, 304–307.
Kumar, G., Banu, S., Murugesan, A.G., 2009. Inﬂuence of Helicteres isora adminis-
tration for diabetes mellitus: its effect on erythrocyte membrane and antiox-
idant status. Food Chem. Toxicol. 47, 1803–1809.
Kunle, O.F., Omoregie, H., Ochogu, P., 2012. Standardization of herbal medicines – a
review. Int. J. Biodivers. Conserv. 4, 101–112.
Lanas, A., 2008. Role of nitric oxide in the gastrointestinal tract. Arthritis Res. Ther.
10 (Suppl. 2), S4.
Lee, A., 2000. Animal models of gastroduodenal ulcer disease. Best Pract. Res. Clin.
Gastroenterol. 14, 75–96.
Levenstein, S., Rosenstock, S., Jacobsen, R.K., Jorgensen, T., 2014. Psychological stress
increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use
of nonsteroidal anti-inﬂammatory drugs. Clin. Gastroenterol. Hepatol.# , http:
//dx.doi.org/10.1016/j.cgh.2014.07.052.
Li, N.-S., Luo, X.-J., Dai, Z., Liu, B., Zhang, Y.-S., Yang, Z.-C., Peng, J., 2012. Beneﬁcial
effects of capsiate on ethanol-induced mucosal injury in rats are related to
stimulation of calcitonin gene-related Peptide release. Planta Med. 78, 24–30.
Li, W., Huang, H., Niu, X., Fan, T., Mu, Q., Li, H., 2013. Protective effect of
tetrahydrocoptisine against ethanol-induced gastric ulcer in mice. Toxicol.
Appl. Pharmacol. 272, 21–29.
Loganayaki, N., Siddhuraju, P., Manian, S., 2013. Antioxidant activity and free radical
scavenging capacity of phenolic extracts from Helicteres isora L. and Ceiba
pentandra L. J. Food Sci. Technol. 50, 687–695.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement
with the Folin phenol reagent. J. Biol. Chem. 193, 265–275.
Mizui, T., Doteuchi, M., 1983. Effect of poliamines on acidiﬁed etanol induced
gastric lesions in rats. Jpn. J. Pharmacol. 33, 939–945.
Musumba, C., Pritchard, D.M., Pirmohamed, M., 2009. Review article: cellular and
molecular mechanisms of NSAID-induced peptic ulcers. Aliment. Pharmacol.
Ther. 30, 517–531.
Ohta, Y., Nishida, K., 2003. Protective effect of coadministered superoxide dismu-
tase and catalase against stress-induced gastric mucosal lesions. Clin. Exp.
Pharmacol. Physiol. 30, 545–550.
Pan, M.-H., Chen, C.-M., Lee, S.-W., Chen, Z.-T., 2008. Cytotoxic triterpenoids from
the root bark of Helicteres angustifolia. Chem. Biodivers. 5, 565–574.
Peskar, B.M., Ehrlich, K., Peskar, B., 2002. Role of ATP-sensitive potassium channels
in prostaglandin-mediated gastroprotection in the rat. J. Pharmacol. Exp. Ther.
301, 969–974.
Pohocha, N., Grampurohit, N.D., 2001. Antispasmodic activity of the fruits of
Helicteres isora Linn. Phytother. Res. 15, 49–52.
Puscas, I., Puscas, C., Coltau, M., Pasca, R., Torres, J., Márquez, M., Herrero, E., Fillat,
O., Ortiz, J.A., 1997. Comparative study of the safety and efﬁcacy of ebrotidine
versus ranitidine and placebo in the prevention of piroxicam-induced gastro-
duodenal lesions. Arzneimittel-Forschung 47, 568–572.
Rogerio, A.P., Fontanari, C., Borducchi, E., Keller, A.C., Russo, M., Soares, E.G.,
Albuquerque, D.A., Faccioli, L.H., 2008. Anti-inﬂammatory effects of Lafoensia
pacari and ellagic acid in a murine model of asthma. Eur. J. Pharmacol. 580,
262–270.
Rozza, A.L., Hiruma-Lima, C.A., Takahira, R.K., Padovani, C.R., Pellizzon, C.H., 2013.
Effect of menthol in experimentally induced ulcers: pathways of gastroprotec-
tion. Chem.-Biol. Interact. 206, 272–278.
Schmeda-Hirschmann, G., Yesilada, E., 2005. Traditional medicine and gastropro-
tective crude drugs. J. Ethnopharmacol. 100, 61–66.
Schubert, M.L., Peura, D.A., 2008. Control of gastric acid secretion in health and
disease. Gastroenterology 134, 1842–1860.
Shay, H., Sun, C.H., Gruenstein, M., D., 1954. A quantitative method for measuring
spontaneous gastric secretion in the rat. Gastroenterology 26, 906–913.
Silva, C., Ferreira, D., Koch, A., Araujo, L., 2010. Variação na arquitetura ﬂoral e
sucesso reprodutivo de duas espécies de Helicteres (Malvaceae), na região
sudoeste de Mato Grosso. Acta Botanica Brasilica 24, 462–468.
Solanki, H.D., Shan, N.J., 2013. Ulcer preventive (antiulcer) activity of Helicteres Isora
fruit extracts. Int. J. Pharm. Res. Bio-Sci. 2, 594–610.
Solon, S., Lopes, L., Teixeira de Sousa, P., Schmeda-Hirschmann, G., 2000. Free
radical scavenging activity of Lafoensia pacari. J. Ethnopharmacol. 72, 173–178.
Suthar, M., Rathore, G.S., Pareek, A., 2009. Antioxidant and antidiabetic activity of
Helicteres isora (L.) fruits. Indian J. Pharm. Sci. 71, 695–699.
Takagi, K., Susumu, O., 1968. A simple method for producing stress ulcers in the rat.
Jpn. J. Pharmacol. 18, 9–18.
Tambekar, D.H., Khante, B.S., Panzade, B.K., Dahikar, S., Banginwar, Y., 2008.
Evaluation of phytochemical and antibacterial potential of Helicteres isora
L. fruits against enteric bacterial pathogens. Afr. J. Tradit. Complement. Altern.
Med. 5, 290–293.
Tarnawski, A., Ahluwalia, A., Jones, M.K., 2013. Gastric cytoprotection beyond
prostaglandins: cellular and molecular mechanisms of gastroprotective and
ulcer healing actions of antacids. Curr. Pharm. Des. 19, 126–132.
Truiti, M.C.T., Ferreira, I.C.P., Zamuner, M.L.M., Nakamura, C. V, Sarragiotto, M.H.,
Souza, M.C., 2005. Antiprotozoal and molluscicidal activities of ﬁve Brazilian
plants. Braz. J. Med. Biol. Res. 38, 1873–1878.
Ueyama, T., Saika, M., Koreeda, C., Senba, E., 1998. Water immersion-restraint stress
induces expression of immediate-early genes in gastrointestinal tract of rats.
Am. J. Physiol. 275, G287–295.
Vattem, D., Shetty, K., 2005. Biological functionality of ellagic acid: a review. J. Food
Biochem. 29, 234–266.
Venkatesh, S., Laxmi, K.S., Reddy, B.M., Ramesh, M., 2007. Antinociceptive activity of
Helicteres isora. Fitoterapia 78, 146–148.
Venkatesh, S., Reddy, G.D., Reddy, Y.S.R., Sathyavathy, D., Reddy, B.M., 2004. Effect of
Helicteres isora root extracts on glucose tolerance in glucose-induced hypergly-
cemic rats. Fitoterapia 75, 364–367.
Vimala, G., Gricilda Shoba, F., 2014. A review on antiulcer activity of few Indian
medicinal plants. Int. J. Microbiol. 2014, 14. http://dx.doi.org/10.1155/2014/
519590.
Wallace, J., 2008. Prostaglandins, NSAIDs, and gastric mucosal protection: why
doesn’t the stomach digest itself. Physiol. Rev. 88, 1547–1565.
Wang, M., Liu, W., 1987. A naphthoquinone from Helicteres angustifolia. Phyto-
chemistry 26, 578–579.
Werner, S.M., 2014. Patient safety and the widespread use of herbs and supple-
ments. Front. Pharmacol. 5, 142.
Xie, Y.-F., Jiao, Q., Guo, S., Wang, F.-Z., Cao, J.-M., Zhang, Z.-G., 2005. Role of
parasympathetic overactivity in water immersion stress-induced gastric muco-
sal lesion in rat. J. Appl. Physiol. 99, 2416–2422.
Zádori, Z.S., Shujaa, N., Brancati, S.B., Hein, L., Gyires, K., 2011. Both α2B- and α2C-
adrenoceptor subtypes are involved in the mediation of centrally induced
gastroprotection in mice. Eur. J. Pharmacol. 669, 115–120.
S.O. Balogun et al. / Journal of Ethnopharmacology 166 (2015) 176–184184
